Personalized Cancer Treatment Global Market Report 2025

Global Personalized Cancer Treatment Market Report 2024

Personalized Cancer Treatment Global Market Report 2025 – By Treatment Type (Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type), By Diagnostic Techniques (Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types), By End-Users (Hospitals And Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Personalized Cancer Treatment Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Personalized Cancer Treatment Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Personalized Cancer Treatment Global Market Report 2025

Proud Members Of

What Is Covered Under Personalized Cancer Treatment Market?

Personalized cancer treatment customizes therapies based on an individual's unique genetic profile and tumor characteristics, to achieve more effective and targeted interventions. This approach enhances treatment plans and improves patient outcomes by examining genetic mutations and biomarkers, compared to traditional one-size-fits-all methods.

The main types of personalized cancer treatment include targeted therapy, immunotherapy, hormone therapy, chemotherapy, radiation therapy, and others. Targeted therapy uses drugs or other substances to precisely identify and attack cancer cells without harming normal cells. Diagnostic techniques such as genomic sequencing, liquid biopsy, immunohistochemistry, in situ hybridization, biomarker testing, and other diagnostic techniques are used for cancer types including breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, and others, and are used by end-users including hospitals and clinics; research institutes; others

Personalized Cancer Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Personalized Cancer Treatment Market Size 2025 And Growth Rate?

The personalized cancer treatment market size has grown rapidly in recent years. It will grow from $181.55 billion in 2024 to $201.57 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to advancements in genomics and molecular biology, increasing prevalence of cancer, a rise in personalized medicine adoption, growing awareness about cancer treatment options, and improved cancer diagnostics and monitoring technologies.

What Is The Personalized Cancer Treatment Market Growth Forecast?

The personalized cancer treatment market size is expected to see rapid growth in the next few years. It will grow to $303.01 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to the expansion of targeted therapies, advancements in AI and machine learning for treatment planning, increasing investment in cancer research, growing demand for precision medicine, and the development of new biomarkers for personalized treatments. Major trends in the forecast period include the rising use of combination therapies, increased integration of digital health tools, growth in the adoption of liquid biopsy techniques, expansion of immunotherapy options, and enhanced focus on patient-centric care models.

Book your 30 minutes free consultation with our research experts

How Is The Personalized Cancer Treatment Market Segmented?

The personalized cancer treatmentmarket covered in this report is segmented –

1) By Treatment Type: Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type

2) By Diagnostic Techniques: Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types

4) By End-Users: Hospitals And Clinics, Research Institutes, Other End Users

Subsegments:

1) By Targeted Therapy: Monoclonal Antibodies, Small Molecule Inhibitors, Angiogenesis Inhibitors, Signal Transduction Inhibitors

2) By Immunotherapy: checkpoint inhibitors, CAR T-Cell Therapy, Cancer Vaccines, Monoclonal Antibodies For Immunotherapy

3) By Hormone Therapy: Anti-Estrogens, Aromatase Inhibitors, Progestins, LHRH Agonists

4) By Chemotherapy: Alkylating Agents, Antimetabolites, Anthracyclines, Taxanes

5) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Brachytherapy, Radioimmunotherapy, Stereotactic Radiosurgery (SRS)

6) By Other Treatment Types: Gene Therapy, Stem Cell Transplantation, Metabolic Therapy, Nanomedicine

What Is Driving The Personalized Cancer Treatment Market? Surge In Cancer Prevalence Fuels Expansion Of Personalized Cancer Treatment Market

The increasing cancer prevalence is expected to propel the growth of the personalized cancer treatment market going forward. The rise in cancer is largely attributed to increasing life expectancy, which leads to more people reaching an age where cancer is more common and growing exposure to risk factors such as tobacco, alcohol, and obesity. Personalized cancer treatments provide targeted and effective therapies to manage diverse cancer types and stages, and this growing burden stimulates investment and innovation in precision medicine, aiming to improve patient outcomes through customized treatment plans. For instance, in February 2024, according to the World Health Organization, a Switzerland-based United Nations agency dedicated to global health and safety, the global cancer burden is projected to rise significantly, with an anticipated 77% increase in new cancer cases, reaching over 35 million by 2050 compared to 20 million in 2022. Therefore, increasing cancer prevalence is driving the growth of the personalized cancer treatment market.

Who Are The Major Players In The Global Personalized Cancer Treatment Market?

Major companies operating in the personalized cancer treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Novartis AG, BioNTech SE, Illumina Inc., Artera, Exact Sciences Corporation., Moffitt Cancer Center, Myriad Genetics, NeoGenomics Laboratories, Guardant Health, Caris Life Sciences, Tempus AI Inc., Foundation Medicine, Immatics, Fate Therapeutics, CureVac AG, TScan Therapeutics, CureMetrix, PDC*line Pharma

What Are The Key Trends Of The Global Personalized Cancer Treatment Market? AI-Driven Analytics Revolutionizing Personalized Cancer Treatment

Major companies operating in the personalized cancer treatment market are focusing on developing innovative solutions, such as artificial intelligence (AI)-enabled multimodal immune profile algorithmic tests, to predict patient responses to immunotherapy and improve personalized treatment strategies. An AI-enabled multimodal immune profile algorithmic test analyzes multiple types of data, including genomic, transcriptomic, and clinical biomarkers, to assess a patient's immune profile and predict their response to immunotherapy to help stratify patients and guide personalized cancer treatments. For instance, in July 2024, Tempus AI, Inc., a US-based health technology company, launched its AI-enabled multimodal immune profile algorithmic test (IPS), marking its first offering in the immunotherapy diagnostics space. The test, available for research use only (RUO), assesses a range of immunotherapy-related biomarkers to generate a score that helps predict patient response to immunotherapy, supporting personalized cancer treatment. The AI-driven immunotherapy-focused diagnostics enhance patient stratification and treatment selection in oncology.

What Are Latest Mergers And Acquisitions In The Personalized Cancer Treatment Market? Pfizer Acquires Seagen To Strengthen Oncology Portfolio

In December 2023, Pfizer Inc., a US-based pharmaceutical and biotechnology corporation, acquired Seagen Inc. for $43 billion. With this acquisition, Pfizer aims to leverage its cutting-edge antibody-drug conjugate technology, enhancing its capabilities in developing targeted cancer therapies. This strategic move aims to accelerate Pfizer's growth in the oncology market, addressing the urgent need for more effective cancer treatments. Seagen Inc. is a US-based biotechnology company focused on developing monoclonal antibody-based therapies for the treatment of cancer.

What Is The Regional Outlook For The Global Personalized Cancer Treatment Market?

North America was the largest region in the personalized cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized cancer treatment market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Personalized Cancer Treatment Market?

The personalized cancer treatment market consists of revenues earned by entities by providing services such as genetic testing, biomarker analysis, personalized therapy formulation, and targeted drug delivery. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized cancer treatment market also includes sales of products including targeted therapy drugs, genomic profiling kits, and companion diagnostics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Personalized Cancer Treatment Industry?

The personalized cancer treatment market research report is one of a series of new reports from the business research company that provides personalized cancer treatment market statistics, including personalized cancer treatment industry global market size, regional shares, competitors with an personalized cancer treatment market share, detailed personalized cancer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the personalized cancer treatment industry. This personalized cancer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Personalized Cancer Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$201.57 billion
Revenue Forecast In 2034	$303.01 billion
Growth Rate	CAGR of 10.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Treatment Type: Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type 2) By Diagnostic Techniques: Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques 3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types 4) By End-Users: Hospitals And Clinics, Research Institutes, Other End Users Subsegments: 1) By Targeted Therapy: Monoclonal Antibodies, Small Molecule Inhibitors, Angiogenesis Inhibitors, Signal Transduction Inhibitors 2) By Immunotherapy: Checkpoint Inhibitors, CAR T-Cell Therapy, Cancer Vaccines, Monoclonal Antibodies For Immunotherapy 3) By Hormone Therapy: Anti-Estrogens, Aromatase Inhibitors, Progestins, LHRH Agonists 4) By Chemotherapy: Alkylating Agents, Antimetabolites, Anthracyclines, Taxanes 5) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Brachytherapy, Radioimmunotherapy, Stereotactic Radiosurgery (SRS) 6) By Other Treatment Types: Gene Therapy, Stem Cell Transplantation, Metabolic Therapy, Nanomedicine
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Novartis AG, BioNTech SE, Illumina Inc., Artera, Exact Sciences Corporation., Moffitt Cancer Center, Myriad Genetics, NeoGenomics Laboratories, Guardant Health, Caris Life Sciences, Tempus AI Inc., Foundation Medicine, Immatics, Fate Therapeutics, CureVac AG, TScan Therapeutics, CureMetrix, PDC*line Pharma
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Personalized Cancer Treatment Market Characteristics

3. Personalized Cancer Treatment Market Trends And Strategies

4. Personalized Cancer Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Personalized Cancer Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Personalized Cancer Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Personalized Cancer Treatment Market Growth Rate Analysis

5.4. Global Personalized Cancer Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Personalized Cancer Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Personalized Cancer Treatment Total Addressable Market (TAM)

6. Personalized Cancer Treatment Market Segmentation

6.1. Global Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Targeted Therapy

Immunotherapy

Hormone Therapy

Chemotherapy

Radiation Therapy

Other Treatment Type

6.2. Global Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genomic Sequencing

Liquid Biopsy

Immunohistochemistry

In Situ Hybridization

Biomarker Testing

Other Diagnostic Techniques

6.3. Global Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Melanoma

Other Cancer Types

6.4. Global Personalized Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Research Institutes

Other End Users

6.5. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal Antibodies

Small Molecule Inhibitors

Angiogenesis Inhibitors

Signal Transduction Inhibitors

6.6. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Checkpoint Inhibitors

CAR T-Cell Therapy

Cancer Vaccines

Monoclonal Antibodies For Immunotherapy

6.7. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Hormone Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anti-Estrogens

Aromatase Inhibitors

Progestins

LHRH Agonists

6.8. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Alkylating Agents

Antimetabolites

Anthracyclines

Taxanes

6.9. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

External Beam Radiation Therapy (EBRT)

Brachytherapy

Radioimmunotherapy

Stereotactic Radiosurgery (SRS)

6.10. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Therapy

Stem Cell Transplantation

Metabolic Therapy

Nanomedicine

7. Personalized Cancer Treatment Market Regional And Country Analysis

7.1. Global Personalized Cancer Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Personalized Cancer Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Personalized Cancer Treatment Market

8.1. Asia-Pacific Personalized Cancer Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Personalized Cancer Treatment Market

9.1. China Personalized Cancer Treatment Market Overview

9.2. China Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Personalized Cancer Treatment Market

10.1. India Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Personalized Cancer Treatment Market

11.1. Japan Personalized Cancer Treatment Market Overview

11.2. Japan Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Personalized Cancer Treatment Market

12.1. Australia Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Personalized Cancer Treatment Market

13.1. Indonesia Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Personalized Cancer Treatment Market

14.1. South Korea Personalized Cancer Treatment Market Overview

14.2. South Korea Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Personalized Cancer Treatment Market

15.1. Western Europe Personalized Cancer Treatment Market Overview

15.2. Western Europe Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Personalized Cancer Treatment Market

16.1. UK Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Personalized Cancer Treatment Market

17.1. Germany Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Personalized Cancer Treatment Market

18.1. France Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Personalized Cancer Treatment Market

19.1. Italy Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Personalized Cancer Treatment Market

20.1. Spain Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Personalized Cancer Treatment Market

21.1. Eastern Europe Personalized Cancer Treatment Market Overview

21.2. Eastern Europe Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Personalized Cancer Treatment Market

22.1. Russia Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Personalized Cancer Treatment Market

23.1. North America Personalized Cancer Treatment Market Overview

23.2. North America Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Personalized Cancer Treatment Market

24.1. USA Personalized Cancer Treatment Market Overview

24.2. USA Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Personalized Cancer Treatment Market

25.1. Canada Personalized Cancer Treatment Market Overview

25.2. Canada Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Personalized Cancer Treatment Market

26.1. South America Personalized Cancer Treatment Market Overview

26.2. South America Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Personalized Cancer Treatment Market

27.1. Brazil Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Personalized Cancer Treatment Market

28.1. Middle East Personalized Cancer Treatment Market Overview

28.2. Middle East Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Personalized Cancer Treatment Market

29.1. Africa Personalized Cancer Treatment Market Overview

29.2. Africa Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Personalized Cancer Treatment Market Competitive Landscape And Company Profiles

30.1. Personalized Cancer Treatment Market Competitive Landscape

30.2. Personalized Cancer Treatment Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Personalized Cancer Treatment Market Other Major And Innovative Companies

31.1. Thermo Fisher Scientific Inc.

31.2. AstraZeneca Plc

31.3. Novartis AG

31.4. BioNTech SE

31.5. Illumina Inc.

31.6. Artera

31.7. Exact Sciences Corporation

31.8. Moffitt Cancer Center

31.9. Myriad Genetics

31.10. NeoGenomics Laboratories

31.11. Guardant Health

31.12. Caris Life Sciences

31.13. Tempus AI Inc.

31.14. Foundation Medicine

31.15. Immatics

32. Global Personalized Cancer Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Personalized Cancer Treatment Market

34. Recent Developments In The Personalized Cancer Treatment Market

35. Personalized Cancer Treatment Market High Potential Countries, Segments and Strategies

35.1 Personalized Cancer Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Personalized Cancer Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Personalized Cancer Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Personalized Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Hormone Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Personalized Cancer Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Personalized Cancer Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Pfizer Inc. Financial Performance

Table 82: Johnson & Johnson Financial Performance

Table 83: F. Hoffmann-La Roche Financial Performance

Table 84: Merck & Co. Inc. Financial Performance

Table 85: Bristol Myers Squibb Company Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Personalized Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Hormone Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Personalized Cancer Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Personalized Cancer Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Pfizer Inc. Financial Performance

Figure 82: Johnson & Johnson Financial Performance

Figure 83: F. Hoffmann-La Roche Financial Performance

Figure 84: Merck & Co. Inc. Financial Performance

Figure 85: Bristol Myers Squibb Company Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

What Is The Healthcare IT Consulting Market Overview In 2022?

How Will The Stem Cell Assay Market Grow In 2022?

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Cancer Immunotherapy Global Market Report 2025 – By Product (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma), By End User (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Solid Tumor Cancer Treatment Global Market Report 2025 – By Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Surgical Procedures), By Application (Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other Applications ), By End-Users (Hospitals, Research Institutes, Homecare) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Endometrial Cancer Treatment Global Market Report 2025 – By Type (Adenocarcinoma, Uterine Carcinosarcoma, Squamous Cell Carcinoma, Small Cell Carcinoma, Transitional Carcinoma, Serous Carcinoma, Other Types), By Diagnosis Method (Biopsy, Pelvic Ultrasound, Hysteroscopy, CT Scan, Other Diagnosis Methods), By Route Of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Metastatic Breast Cancer Treatment Global Market Report 2025 – By Therapy Type (Chemotherapy, Radiation Therapy, Biologic Targeted Therapy, Breast Surgery, Hormone Therapy), By Molecule Type (Monoclonal Antibody, Peptides, Polymer, Small Molecule, Gene Therapy), By Route Of Administration (Oral, Parenteral), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Bone Cancer Treatment Global Market Report 2025 – By Type (Multiple Myeloma, Osteosarcoma, Chondrosarcoma, Ewing Sarcoma), By Treatment Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Surgery, Other Treatment Types), By Distribution Channel (Hospital Pharmacies, Drug Store And Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Esophageal Cancer Global Market Report 2025 – By Type (Esophageal Squamous-Cell Carcinoma, Esophageal Adenocarcinoma, Other Types), By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End Users (Hospitals, Homecare, Specialty Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Appendiceal Cancer Treatment Global Market Report 2025 – By Type (Colonic-Type Adenocarcinoma, Mucinous Adenocarcinoma Of Appendix, Goblet Cell Adenocarcinoma, Neuroendocrine Carcinoma, Other Types), By Treatment (Surgery, Chemotherapy, Radiation Therapy, Other Treatments), By Route Of Administration (Oral, Intravenous, Other Routes of Administration), By End User (Hospitals, Cancer Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

AI In Cancer Diagnostics Global Market Report 2025 – By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types), By Application (Screening And Diagnosis, Tumor Identification, Monitoring), By End User (Hospitals, Diagnostic Centers, Medical Research Institutes, Contract Research Organizations) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Personalized Cancer Treatment market?

How will the Personalized Cancer Treatment market drivers and restraints affect the market dynamics? What forces will shape the Personalized Cancer Treatment industry going forward?

The Personalized Cancer Treatment market major growth driver - Surge In Cancer Prevalence Fuels Expansion Of Personalized Cancer Treatment Market. For further insights on the Personalized Cancer Treatment market, request a sample here

What is the forecast market size or the forecast market value of the Personalized Cancer Treatment market?

The Personalized Cancer Treatment market size has grown strongly in recent years. The personalized cancer treatment market size has grown rapidly in recent years. It will grow from $181.55 billion in 2024 to $201.57 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to advancements in genomics and molecular biology, increasing prevalence of cancer, a rise in personalized medicine adoption, growing awareness about cancer treatment options, and improved cancer diagnostics and monitoring technologies. The personalized cancer treatment market size is expected to see rapid growth in the next few years. It will grow to $303.01 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to the expansion of targeted therapies, advancements in AI and machine learning for treatment planning, increasing investment in cancer research, growing demand for precision medicine, and the development of new biomarkers for personalized treatments. Major trends in the forecast period include the rising use of combination therapies, increased integration of digital health tools, growth in the adoption of liquid biopsy techniques, expansion of immunotherapy options, and enhanced focus on patient-centric care models. For further insights on the Personalized Cancer Treatment market, request a sample here

How is the Personalized Cancer Treatment market segmented?

The personalized cancer treatmentmarket covered in this report is segmented –
1) By Treatment Type: Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type
2) By Diagnostic Techniques: Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types
4) By End-Users: Hospitals And Clinics, Research Institutes, Other End Users
Subsegments:
1) By Targeted Therapy: Monoclonal Antibodies, Small Molecule Inhibitors, Angiogenesis Inhibitors, Signal Transduction Inhibitors
2) By Immunotherapy: Checkpoint Inhibitors, CAR T-Cell Therapy, Cancer Vaccines, Monoclonal Antibodies For Immunotherapy
3) By Hormone Therapy: Anti-Estrogens, Aromatase Inhibitors, Progestins, LHRH Agonists
4) By Chemotherapy: Alkylating Agents, Antimetabolites, Anthracyclines, Taxanes
5) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Brachytherapy, Radioimmunotherapy, Stereotactic Radiosurgery (SRS)
6) By Other Treatment Types: Gene Therapy, Stem Cell Transplantation, Metabolic Therapy, Nanomedicine For further insights on the Personalized Cancer Treatment market, request a sample here

Which region has the largest share of the Personalized Cancer Treatment market? What are the other regions covered in the report?

North America was the largest region in the personalized cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Personalized Cancer Treatment market, request a sample here.

Who are the major players in the Personalized Cancer Treatment market?

What are the key trends in the Personalized Cancer Treatment market?

Major trends in the Personalized Cancer Treatment market include AI-Driven Analytics Revolutionizing Personalized Cancer Treatment. For further insights on the Personalized Cancer Treatment market, request a sample here.

What are the major opportunities in the Personalized Cancer Treatment market? What are the strategies for the Personalized Cancer Treatment market?

For detailed insights on the major opportunities and strategies in the Personalized Cancer Treatment market, request a sample here.

How does the Personalized Cancer Treatment market relate to the overall economy and other similar markets?

For detailed insights on Personalized Cancer Treatment's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Personalized Cancer Treatment industry?

For detailed insights on the mergers and acquisitions in the Personalized Cancer Treatment industry, request a sample here.

What are the key dynamics influencing the Personalized Cancer Treatment market growth? SWOT analysis of the Personalized Cancer Treatment market.

For detailed insights on the key dynamics influencing the Personalized Cancer Treatment market growth and SWOT analysis of the Personalized Cancer Treatment industry, request a sample here.